This manuscript reports a secondary cross-sectional analysis of the Comparison of Two Screening Strategies for Gestational Diabetes trial (GDM2) with N = 718 pregnant participants. The analysis focused on mid-pregnancy dietary patterns and their associations with prenatal depressive symptomatology measured in the same period. The authors framed the work within the emerging field of chrononutrition, investigating how the timing and structure of food intake relate to mental health during pregnancy.
Dietary data came from 24-hour dietary recalls collected at mid-pregnancy. From these recalls the investigators derived multiple domains relevant to chrononutrition: direct timing of eating episodes, energy timing (proportion of daily energy at different meals), meal and snack structure (including eating and snack frequency), meal energy distribution (energy across eating episodes and quartiles), and overall diet quality. Specific operational definitions for each domain were described in the parent study; the source reports results for these derived indicators as predictors of depressive symptom outcomes.
Depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale (EPDS). Mean EPDS score in the sample was 6.3 with a standard deviation of 4.9. Using a commonly applied cutoff, 12.4% (n = 89) of participants were classified as having high depressive symptoms (EPDS ≥13). The authors examined associations both with continuous EPDS total score and with the binary classification of high depressive symptoms.
The investigators used generalized linear models to evaluate associations between the chrononutrition indicators and depressive symptom outcomes. Models produced regression coefficients for associations with total EPDS score and prevalence ratios for associations with high depressive symptoms (EPDS ≥13). Reported associations include point estimates, confidence intervals, and p values for individual chrononutrition indicators.
Several intake frequency and energy indicators were positively associated with greater total depressive symptoms. Specifically, higher overall eating frequency was associated with higher EPDS total score (reported B = 0.08, 95% CI [0.02, 0.14], p = 0.009). Likewise, higher snack frequency (B = 0.06, 95% CI [0.00, 0.12], p = 0.040) and increased nighttime snacking frequency (B = 0.06, 95% CI [0.00, 0.11], p = 0.041) were associated with higher total depressive symptoms. Total daily energy intake also showed a positive association with EPDS total score (B = 0.06, 95% CI [0.01, 0.12], p = 0.031).
In analyses of high depressive symptoms (EPDS ≥13), the source reports that greater energy intake from breakfast was associated with a higher prevalence of high depressive symptoms (prevalence ratio and confidence interval reported in the source: PR = 1.2 [1.0, 1.3], p = 0.017).
Opposing associations were observed for some timing and energy distribution indicators. Greater energy intake from dinner was associated with a lower prevalence of high depressive symptoms (PR = 0.81, 95% CI [0.69, 0.94], p = 0.007). A later timing of the first eating episode was associated with a lower prevalence of high depressive symptoms (PR = 0.83, 95% CI [0.70, 0.99], p = 0.034). Participants in the first quartile for first-energy intake had a lower prevalence of high depressive symptoms compared with later quartiles (PR = 0.84, 95% CI [0.70, 1.0], p = 0.048).
The authors conclude that these findings extend prior chrononutrition–depression literature into the prenatal period, implicating eating frequency, overall energy intake, and the timing and distribution of meal energy as correlates of prenatal depressive symptomatology. The analysis is cross-sectional and observational; the source explicitly notes the need for further longitudinal investigation to clarify temporality and causality. Any mechanistic explanations or clinical recommendations beyond these associations were not asserted in the source.
The University of Pittsburgh Institutional Review Board provided ethical approval for the work, with oversight from the trial’s data and safety monitoring board and the Clinical and Translational Science Institute at the University of Pittsburgh. The parent GDM2 trial was registered at ClinicalTrials.gov (NCT02309138). The source reports that data can be made available upon reasonable request and a data use agreement with the study principal investigator. Conflicts of interest disclosed in the source include consulting and honoraria for some authors; other listed authors reported no conflicts.
Overall, the source reports cross-sectional associations between multiple mid-pregnancy chrononutrition indicators and prenatal depressive symptoms measured by the EPDS, highlighting several statistically significant associations that merit follow-up in longitudinal designs.